Fludarabine Melphalan and Alemtuzumab (Campath) Conditioning for Pts with High Risk Myeloid Malignancies. High Cure Rate for Pts with Low Leukemia Burden.

Autor: van Besien, Koen W., Artz, Andrew, Smith, Sonali, Rich, Elizabeth, Godley, Lucy, Jones, Demetria *, Cerro, Paula Del *, Switzer, Diane *, Casey, Brendan, Odenike, Olatoyosi, Thirman, Michael, Daugherty, Chris *, Zimmerman, Todd M., Larson, Richard, Stock, Wendy
Zdroj: In Blood 16 November 2004 104(11):2321-2321
Databáze: ScienceDirect